documents: FDA-2005-D-0208-0001

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2005-D-0208-0001 FDA FDA-2005-D-0208 Guidance for Industry: Safety, Efficacy, and Pharmacokinetic Studies to Support Marketing of Immune Globulin Intravenous (Human) as Replacement Therapy for Primary Humoral Immunodeficiency; Availability Notice NAD-Notice of Availability of Data 2005-12-02T05:00:00Z 2005 12 2005-11-30T05:00:00Z 2006-03-02T04:59:59Z 2008-07-18T05:09:10Z   0 0 0900006480441234

Links from other tables